Pages that link to "Q37977794"

The following pages link to Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children. (Q37977794):

Displaying 24 items.

• Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review (Q34277471) (← links)
• Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. (Q34473940) (← links)
• Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru (Q34493821) (← links)
• Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia (Q35425552) (← links)
• Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines (Q35679740) (← links)
• Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context? (Q36341662) (← links)
• A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries (Q37153913) (← links)
• Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia (Q37321084) (← links)
• Treatment costs of diarrheal disease and all-cause pneumonia among children under-5 years of age in Colombia. (Q38115371) (← links)
• Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. (Q38115373) (← links)
• 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents (Q38137006) (← links)
• Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014). (Q38355461) (← links)
• Estimating costs of care for meningitis infections in low- and middle-income countries (Q38445981) (← links)
• Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia (Q38602904) (← links)
• Streptococcus pneumoniae serotype 19A: Worldwide epidemiology (Q38637072) (← links)
• Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review (Q38924170) (← links)
• Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned (Q38966571) (← links)
• Cost-effectiveness analysis of pneumococcal vaccination for infants in China. (Q38997767) (← links)
• Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis. (Q39041609) (← links)
• How cost effective is switching universal vaccination from PCV10 to PCV13? A case study from a developing country (Q56879709) (← links)
• How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia (Q56879722) (← links)
• Serotype Epidemiology among PCV-10 Vaccinated and Unvaccinated Children at Gertrude's Children's Hospital, Nairobi County: A Cross-Sectional Study (Q64234282) (← links)
• Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia (Q88296826) (← links)
• Economic Impact of Pneumococcal Protein-D Conjugate Vaccine (PHiD-CV) on the Malaysian National Immunization Programme (Q88495665) (← links)